News Conference News AHA 2017 Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events Michael O'Riordan November 17, 2017
News Conference News AHA 2017 Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI Yael L. Maxwell November 13, 2017
News Conference News AHA 2017 CANTOS: Big Drop in CVD Events Among Canakinumab Responders Michael O'Riordan November 13, 2017
News Features COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict Todd Neale September 15, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
News Daily News CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition Michael O'Riordan August 04, 2017
News Daily News CANTOS: Canakinumab Cuts Combo of MI, Stroke, CV Death in Post-MI Patients With Elevated CRP Todd Neale June 22, 2017
News Daily News More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds Todd Neale May 05, 2017
News Daily News HEART Pathway as Safe as Usual Care for Chest Pain in the Emergency Department Caitlin E. Cox April 25, 2017
News Daily News ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events Michael O'Riordan April 04, 2017
News Daily News Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS Todd Neale February 08, 2017
News Daily News Meta-analysis Adds Support to More Intensive Lowering of BP in Older Patients With Hypertension Todd Neale January 30, 2017